XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Operations - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Condensed Consolidated Statements of Operations        
Sales $ 0 $ 0 $ 0 $ 0
Cost of goods sold - warranty adjustment (see note 5) 180,000 0 27,000 1,000
Gross loss (180,000) 0 (27,000) (1,000)
Operating expenses:        
Research and development, net of grants 362,000 796,000 1,590,000 2,563,000
General and administrative 1,135,000 1,342,000 3,459,000 4,399,000
Total operating expenses 1,497,000 2,138,000 5,049,000 6,962,000
Loss from operations (1,677,000) (2,138,000) (5,076,000) (6,963,000)
Other income:        
Other Income 0 0 44,000 0
Interest income 0 30,000 1,000 100,000
Net loss (1,677,000) (2,108,000) (5,031,000) (6,863,000)
Net loss attributed to non-controlling interest 0 0 1,000 0
Net loss attributed to common stockholders $ (1,677,000) $ (2,108,000) $ (5,030,000) $ (6,863,000)
Net loss per share - basic and fully diluted $ (0.06) $ (0.08) $ (0.19) $ (0.26)
Weighted average number of shares outstanding - basic and fully diluted 27,839,597 26,702,288 27,089,142 26,699,825